[go: up one dir, main page]

WO2011124895A3 - Phospholipid-containing pharmaceutical and nutraceutical compositions - Google Patents

Phospholipid-containing pharmaceutical and nutraceutical compositions Download PDF

Info

Publication number
WO2011124895A3
WO2011124895A3 PCT/GB2011/000548 GB2011000548W WO2011124895A3 WO 2011124895 A3 WO2011124895 A3 WO 2011124895A3 GB 2011000548 W GB2011000548 W GB 2011000548W WO 2011124895 A3 WO2011124895 A3 WO 2011124895A3
Authority
WO
WIPO (PCT)
Prior art keywords
phospholipid
containing pharmaceutical
nutraceutical compositions
physiologically tolerable
lipophilic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2011/000548
Other languages
French (fr)
Other versions
WO2011124895A2 (en
Inventor
Kurt Ingar Draget
Ingvild Haug
Anne-Ma H. Carlsen
Tore Seternes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AYANDA GROUP AS
Original Assignee
AYANDA GROUP AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AYANDA GROUP AS filed Critical AYANDA GROUP AS
Publication of WO2011124895A2 publication Critical patent/WO2011124895A2/en
Anticipated expiration legal-status Critical
Publication of WO2011124895A3 publication Critical patent/WO2011124895A3/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

This invention provides a pharmaceutical composition comprising a physiologically tolerable phospholipid selected from the group consisting of marine phospholipids and lecithin and said physiologically tolerable phospholipid having dispersed therein a physiologically tolerable, lipophilic, structure disrupting agent phospholipid having lipophilic, structure disrupting agent.
PCT/GB2011/000548 2010-04-09 2011-04-08 Phospholipid-containing pharmaceutical and nutraceutical compositions Ceased WO2011124895A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1006012.7A GB201006012D0 (en) 2010-04-09 2010-04-09 Composition
GB1006012.7 2010-04-09

Publications (2)

Publication Number Publication Date
WO2011124895A2 WO2011124895A2 (en) 2011-10-13
WO2011124895A3 true WO2011124895A3 (en) 2012-11-22

Family

ID=42236133

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2011/000548 Ceased WO2011124895A2 (en) 2010-04-09 2011-04-08 Phospholipid-containing pharmaceutical and nutraceutical compositions

Country Status (2)

Country Link
GB (1) GB201006012D0 (en)
WO (1) WO2011124895A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY39010A (en) * 2020-01-10 2021-08-31 Monsanto Technology Llc AUXIN HERBICIDE COMPOSITIONS INCLUDING DRIFT RETARDING AGENTS AND METHODS OF PREPARING THEM

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2194842A (en) * 1936-02-25 1940-03-26 American Lecithin Co Soft lecithin preparation
US2494771A (en) * 1947-01-30 1950-01-17 Cargill Inc Phosphatide composition and shortening and methods for making same
US2555972A (en) * 1948-03-27 1951-06-05 Central Soya Co Preparation of phosphatides
US4842865A (en) * 1986-04-24 1989-06-27 A. Nattermann & Cie Gmbh Use of glycofurol for the liquidization of pharmaceutical preparations to be filled into soft gelatine capsules
GB2282586A (en) * 1993-09-28 1995-04-12 Scherer Gmbh R P Soft gelatin capsule manufacture
US5536729A (en) * 1993-09-30 1996-07-16 American Home Products Corporation Rapamycin formulations for oral administration
WO2002056709A1 (en) * 2001-01-17 2002-07-25 R.P. Scherer Technologies, Inc. Ingestible compositions containing an odoriferous oil
WO2003009704A2 (en) * 2001-07-27 2003-02-06 N.V. Nutricia Enteral compositions for the prevention and/or treatment of sepsis
FR2880538A1 (en) * 2005-01-07 2006-07-14 Polaris Soc Par Actions Simpli Composition, useful in an anti-inflammatory and moisturizing for skin, comprises fish oil and phospholipids
WO2008117062A1 (en) * 2007-03-28 2008-10-02 Aker Biomarine Asa Bioeffective krill oil compositions
WO2010097701A1 (en) * 2009-02-26 2010-09-02 Aker Biomarine Asa Low viscosity phospholipid compositions

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2194842A (en) * 1936-02-25 1940-03-26 American Lecithin Co Soft lecithin preparation
US2494771A (en) * 1947-01-30 1950-01-17 Cargill Inc Phosphatide composition and shortening and methods for making same
US2555972A (en) * 1948-03-27 1951-06-05 Central Soya Co Preparation of phosphatides
US4842865A (en) * 1986-04-24 1989-06-27 A. Nattermann & Cie Gmbh Use of glycofurol for the liquidization of pharmaceutical preparations to be filled into soft gelatine capsules
GB2282586A (en) * 1993-09-28 1995-04-12 Scherer Gmbh R P Soft gelatin capsule manufacture
US5536729A (en) * 1993-09-30 1996-07-16 American Home Products Corporation Rapamycin formulations for oral administration
WO2002056709A1 (en) * 2001-01-17 2002-07-25 R.P. Scherer Technologies, Inc. Ingestible compositions containing an odoriferous oil
WO2003009704A2 (en) * 2001-07-27 2003-02-06 N.V. Nutricia Enteral compositions for the prevention and/or treatment of sepsis
FR2880538A1 (en) * 2005-01-07 2006-07-14 Polaris Soc Par Actions Simpli Composition, useful in an anti-inflammatory and moisturizing for skin, comprises fish oil and phospholipids
WO2008117062A1 (en) * 2007-03-28 2008-10-02 Aker Biomarine Asa Bioeffective krill oil compositions
WO2010097701A1 (en) * 2009-02-26 2010-09-02 Aker Biomarine Asa Low viscosity phospholipid compositions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DR. POEHLMANN & CO. GMBH: "Voltax Kapseln", 1 March 2002 (2002-03-01), XP002681796, Retrieved from the Internet <URL:http://www.dr-poehlmann.de/pdf/gi_voltax_kapseln.pdf> [retrieved on 20120814] *

Also Published As

Publication number Publication date
GB201006012D0 (en) 2010-05-26
WO2011124895A2 (en) 2011-10-13

Similar Documents

Publication Publication Date Title
WO2011128630A3 (en) Anti-abuse gelled pharmaceutical compositions
WO2011115684A3 (en) Lipid vesicle compositions and methods of use
WO2007101551A3 (en) Phospholipid complexes of curcumin having improved bioavailability
WO2012174158A3 (en) Administration of benzodiazepine
WO2011153493A3 (en) Biodegradable lipids for the delivery of active agents
WO2010019239A3 (en) Pharmaceutical composition of n- [2,4-bis (1, 1 -dimethylethyl) - 5 - hydroxyphenyl] - 1, 4 - dihydro - 4 - oxoquinoline - 3 - carboxamide and administration thereof
WO2009121039A3 (en) Administration of benzodiazepine compositions
MX2011010835A (en) Sublingual pharmaceutical composition comprising a neutral oil.
MX2012001939A (en) Pharmaceutical composition and administrations thereof.
MX2009010372A (en) Novel composition based on cholest-4-ene-3-one oxime.
WO2012009723A8 (en) C-met modulator pharmaceutical compositions
TN2012000392A1 (en) Oral formulations and lipophilic salts of methylnaltrexone
IL222578A0 (en) Method for preparing pharmaceutical compositions intended for oral administration comprising one or more active ingredients and the compositions comprising same
WO2011128627A3 (en) Oral veterinary pharmaceutical and nutraceutical compositions
MX2014002362A (en) Formulations and dosage forms of oxidized phospholipids.
WO2013134534A3 (en) Solid state forms of cabazitaxel and processes for preparation thereof
WO2012119781A3 (en) Novel lipids, phospholipids, phospholipid and lipid compositions and their use
EP2723345A4 (en) Composition comprising phosphatidylcholine as an active ingredient for attenuating toxicity of anticancer agent
TN2009000510A1 (en) Extended release formulation of nevirapine
WO2009100886A3 (en) Formulations of flibanserin
WO2013170086A3 (en) Formulations for the delivery of active ingredients
WO2011009851A3 (en) Walnut extracts for nutraceutical applications
WO2011143271A3 (en) Therapeutic liposomes and methods for producing and using the same
WO2012080176A3 (en) Pharmaceutical compositions comprising alisporivir
EP2335698B8 (en) Pharmaceutical solid preparation having active ingredients separated by boundary therein

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11715596

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11715596

Country of ref document: EP

Kind code of ref document: A2